216 related articles for article (PubMed ID: 10399622)
21. Chronic systemic pesticide exposure reproduces features of Parkinson's disease.
Betarbet R; Sherer TB; MacKenzie G; Garcia-Osuna M; Panov AV; Greenamyre JT
Nat Neurosci; 2000 Dec; 3(12):1301-6. PubMed ID: 11100151
[TBL] [Abstract][Full Text] [Related]
22. Overview of the extranigral aspects of Parkinson disease.
Lim SY; Fox SH; Lang AE
Arch Neurol; 2009 Feb; 66(2):167-72. PubMed ID: 19204152
[TBL] [Abstract][Full Text] [Related]
23. Degeneration of the locus ceruleus noradrenergic neurons in the stress-induced depression of rats.
Kitayama IT; Otani M; Murase S
Ann N Y Acad Sci; 2008 Dec; 1148():95-8. PubMed ID: 19120095
[TBL] [Abstract][Full Text] [Related]
24. Locus coeruleus.
Benarroch EE
Cell Tissue Res; 2018 Jul; 373(1):221-232. PubMed ID: 28687925
[TBL] [Abstract][Full Text] [Related]
25. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
26. Norepinephrine: The redheaded stepchild of Parkinson's disease.
Rommelfanger KS; Weinshenker D
Biochem Pharmacol; 2007 Jul; 74(2):177-90. PubMed ID: 17416354
[TBL] [Abstract][Full Text] [Related]
27. Transgenic mice overexpressing the full-length neurotrophin receptor TrkC exhibit increased catecholaminergic neuron density in specific brain areas and increased anxiety-like behavior and panic reaction.
Dierssen M; Gratacòs M; Sahún I; Martín M; Gallego X; Amador-Arjona A; Martínez de Lagrán M; Murtra P; Martí E; Pujana MA; Ferrer I; Dalfó E; Martínez-Cué C; Flórez J; Torres-Peraza JF; Alberch J; Maldonado R; Fillat C; Estivill X
Neurobiol Dis; 2006 Nov; 24(2):403-18. PubMed ID: 16963267
[TBL] [Abstract][Full Text] [Related]
28. Depression and dementia in Parkinson's disease. Catecholamine changes in the locus ceruleus, a basis for therapy.
Chan-Palay V
Adv Neurol; 1993; 60():438-46. PubMed ID: 8093581
[No Abstract] [Full Text] [Related]
29. Locus coeruleus promotes survival of dopamine neurons in ventral mesencephalon. An in oculo grafting study.
Berglöf E; Strömberg I
Exp Neurol; 2009 Mar; 216(1):158-65. PubMed ID: 19150447
[TBL] [Abstract][Full Text] [Related]
30. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.
Maingay M; Romero-Ramos M; Carta M; Kirik D
Neurobiol Dis; 2006 Sep; 23(3):522-32. PubMed ID: 16806952
[TBL] [Abstract][Full Text] [Related]
31. The anatomy and pigmentation of the human substantia nigra in relation to selective neuronal vulnerability.
Gibb WR; Fearnley JM; Lees AJ
Adv Neurol; 1990; 53():31-4. PubMed ID: 2173373
[No Abstract] [Full Text] [Related]
32. The globus pallidus pars externa and Parkinson's disease. Ready for prime time?
Obeso JA; Rodriguez-Oroz MC; Javier Blesa F; Guridi J
Exp Neurol; 2006 Nov; 202(1):1-7. PubMed ID: 16920102
[No Abstract] [Full Text] [Related]
33. Genetic contributions to Parkinson's disease.
Huang Y; Cheung L; Rowe D; Halliday G
Brain Res Brain Res Rev; 2004 Aug; 46(1):44-70. PubMed ID: 15297154
[TBL] [Abstract][Full Text] [Related]
34. Research in motion: the enigma of Parkinson's disease pathology spread.
Brundin P; Li JY; Holton JL; Lindvall O; Revesz T
Nat Rev Neurosci; 2008 Oct; 9(10):741-5. PubMed ID: 18769444
[TBL] [Abstract][Full Text] [Related]
35. Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat.
González-Hernández T; Barroso-Chinea P; Rodríguez M
Mov Disord; 2004 Sep; 19(9):1029-1042. PubMed ID: 15372592
[TBL] [Abstract][Full Text] [Related]
36. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology.
Braak H; de Vos RA; Bohl J; Del Tredici K
Neurosci Lett; 2006 Mar; 396(1):67-72. PubMed ID: 16330147
[TBL] [Abstract][Full Text] [Related]
37. The basal ganglia circuits, dopamine, and ambiguous word processing: a neurobiological account of priming studies in Parkinson's disease.
Chenery HJ; Angwin AJ; Copland DA
J Int Neuropsychol Soc; 2008 May; 14(3):351-64. PubMed ID: 18419834
[TBL] [Abstract][Full Text] [Related]
38. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.
Howells DW; Porritt MJ; Wong JY; Batchelor PE; Kalnins R; Hughes AJ; Donnan GA
Exp Neurol; 2000 Nov; 166(1):127-35. PubMed ID: 11031089
[TBL] [Abstract][Full Text] [Related]
39. Iron as a vulnerability factor in nigrostriatal degeneration in aging and Parkinson's disease.
Floor E
Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):709-20. PubMed ID: 10875434
[TBL] [Abstract][Full Text] [Related]
40. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains.
Smith Y; Villalba R
Mov Disord; 2008; 23 Suppl 3():S534-47. PubMed ID: 18781680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
